Drug intelligence / Profile preview

recombinant parvalbumin

Development stage
Preclinical
Lead developer
Academic Medical Center
Modality
Recombinant Proteins and Enzymes
Administration
Intraarticular, Oral, Subcutaneous
01

Overview

Recombinant parvalbumin is a recombinant form of the calcium-binding protein parvalbumin (Pvalb). In the context of osteoarthritis, parvalbumin acts as an intracellular calcium chelator and mechanotransducer in osteocytes [1.1]. Under excessive mechanical loading, osteocytic parvalbumin is downregulated, leading to intracellular calcium overload, osteocyte apoptosis, and activation of the Ca²⁺-calmodulin-CaMKIV-CREB-RANKL pathway, which drives pathological subchondral bone remodeling and cartilage degeneration [1.1]. Bone-targeted delivery of recombinant parvalbumin has been shown to attenuate these pathological changes in preclinical models of osteoarthritis [1.1]. Additionally, recombinant parvalbumin from fish species (such as carp Cyp c 1 or cod Gad c 1) and its hypoallergenic mutants have been investigated as allergen-specific immunotherapy (AIT) for the treatment of fish allergy.

Other names
rCyp c 1rGad c 1rPvalbrecombinant Pvalbrecombinant carp parvalbuminrecombinant cod parvalbumin
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on recombinant parvalbumin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on recombinant parvalbumin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call